Conference Details : Topics			Register Online
Venue Home | Topics | Agenda | CME Information    Topics (mouse over the title headings below to view detailed information)   Autism Autism Screening in Primary Care: 1 in 152? WhatÕs a Clinician to Do?   Rotavirus Tools for Managing Rotavirus and Understanding Disease Prevention   HPV Integrating HPV Vaccination Into Contemporary Pediatric Practice: Strategies for Success   Asthma Comprehensive Management of Pediatric Asthma: Using the Guidelines to Develop Effective, Long-term Plans   Bacterial Conjunctivitis Think Pink! Conjunctivitis and the Red Eye   ADHD Translating Evidence to Practice * Advances in the Management of ADHD *Topics subject to change Print All Click below to register for this program online. Register for this Program (or call toll free: 877-594-1770)   Philadelphia, PA 9/27/2008 Baltimore, MD 11/1/2008 Chicago, IL 11/8/2008 Hollywood, CA 11/15/2008 Dearborn, MI 11/20/2008

Home | Conferences | Partners | Online CME | Links | About Us | Become a Member | Research Opportunities | Needs Analysis
© 2006 Primary Care Network

Overview
One in 152: autism affects more children than diabetes, cancer, and AIDS combined. While there is no cure for autism, early diagnosis and intensive treatment significantly increases the chances of the child leading an active and full life. Autism Spectrum Disorders (ASD), on the rise globally, challenges the primary care clinicians to make an early diagnosis with proper screening tools. This program will provide the latest information on ASD and facilitate early diagnosis to improve the long-term outcome for the child, their family, and community.

Objectives
Identify the criteria and specific symptoms of ASD for early diagnosis

Identify screening tools for ASD and administer them to patients with possible developmental delays

Faculty
Marilyn Augustyn, MD
Division Director
Developmental and Behavioral Pediatrics
Boston Medical Center
Boston MA

Overview
This CME activity will provide primary care clinicians with the tools needed to better understand rotavirus prevention and management. The goal of this educational activity is to provide primary care clinicians with the education to work toward decreasing the overall impact of rotavirus in the US.

Objectives
Expand clinician knowledge of the safety and efficacy of the rotavirus vaccine and risk benefits and increase the level of effective management of rotavirus for those patients who have not received the vaccine

Describe the ages at which it is appropriate to administer the rotavirus vaccine and name one method to help prevent rotavirus transmission within the home setting

Faculty
Mary Allen Staat, MD, MPH
Director, International Adoption Center
Associate Professor of Pediatrics
University of Cincinnati College of Medicine
Cincinnati, OH

Overview
Human papillomavirus (HPV) is the most common newly acquired sexually transmitted infection in the United States. It is a necessary cause of cervical cancer and genital warts, and is associated with other anogenital and head and neck cancers, and recurrent respiratory papillomatosis. As HPV is most prevalent among young, sexually active individuals, prevention through prophylactic HPV vaccination of preadolescents and adolescents before they become sexually active provides the maximum health benefit. Two vaccines have been developed: a quadrivalent HPV (6, 11, 16, 18) vaccine, approved by the US Food and Drug Administration (FDA), and a bivalent HPV (16, 18) vaccine, currently under FDA review. Both vaccines have demonstrated lasting efficacy against HPV-associated cervical disease and are generally well tolerated. This program will review the health consequences of HPV infection, provide an update on the safety and efficacy of HPV vaccines, including recent data to expand the benefits of vaccination, and address common barriers to implementing HPV vaccination into pediatric practice.

Objectives
Describe the health consequences associated with HPV infection

Discuss the benefits of HPV vaccination with adolescent patients and their parents

Faculty
Lawrence S. Friedman, MD
Professor of Pediatrics and Internal Medicine
University of California, San Diego
Medical Director, Ambulatory Care and Quality and Safety
UCSD Medical Center
San Diego, CA

Gregory Brotzman, MD
Professor of Family and Community Medicine
Medical College of Wisconsin
Milwaukee, WI

Overview
This educational activity is designed to give clinicians an overview of asthma as a heterogeneous disease and its implication for individual treatment. It will also provide guidance for using the NAEPP EPR 3 guidelines as part of a comprehensive, long-term asthma management plan custom tailored for the needs of each individual patient. NAEPP EPR 3 domains of asthma control include measures of assessment and monitoring; control of factors that contribute to asthma severity; pharmacologic therapy; and education for a partnership in asthma.

Objectives
Understand why the updated NAEPP EPR 3 guidelines are useful in treatment of pediatric patients with asthma and name the 2 domains for assessing asthma control

Name the symptoms of asthma and understand how to effectively monitor their asthma patients by naming the specific time intervals to ensure that patients maintain optimal control

Faculty
Don Bukstein, MD
Associate Clinical Professor
University of Wisconsin - Madison
Director of Allergy and Asthma Research
Dean Medical Center
Madison, WI

Overview
Pediatric and primary care clinicians are usually the first to treat patients with conjunctivitis or red eye, a term that is used to describe any number of conditions that cause inflammation and infection of the eye. By differentiating the serious red eye conditions from the more common diseases, clinicians can not only save the patientÕs eyesight, but perhaps even their life. This program will address the symptoms associated with conjunctivitis and the red eye and provide guidelines for proper diagnosis and treatment.

Objectives
Identify at least 2 pediatric red eye emergencies that require immediate referral to ophthalmology

Distinguish between viral and bacterial conjunctivitis by using the latest diagnostic techniques, employ effective treatment and management strategies to avoid antibiotic resistance, and prevent infectious epidemic

Faculty
Tommy Korn, MD, FACS
Attending Ophthalmologist, Sharp Memorial Hospital
Sharp Rees-Stealy Medical Group
San Diego, CA

Overview
Using the latest evidence related to the safety, efficacy, and tolerability profiles of current treatment options, combined with improved skills in recognition and diagnosis, physicians can be poised to deliver up-to-date, evidence-based care to their patients with ADHD.

Objectives
Recognize the importance of early identification of symptoms for improved diagnosis and treatment of children and adolescents with ADHD

Compare and contrast the current treatment options for children and adolescents with ADHD and develop individualized management strategies for each patient

Faculty
Peter Knoblich, MD
Physician, Private Practice
Roseville, CA

James J. McGough, MD
Professor of Clinical Psychiatry
Director, UCLA Clinical Programs in Attention Deficit Hyperactivity Disorders
Semel Institute for Neuroscience and Human Behavior
David Geffen School of Medicine, University of California
Los Angeles, CA